Saturday, September 29, 2018

Bioequivalence & Bioavailability; Some Perspectives (MABB) - Juniper Publishers

Bioequivalence & Bioavailability; Some Perspectives in Juniper in Modern Applications of Bioequivalence & Bioavailability

The term “bioequivalence” refers to pharmaceutically equivalent products where the extent of bioavailability of the actives are not significantly (in the statistical sense) different under scientific conditions usually following the rules of scientific sampling. As a student of the famous W.E. Deming (1900-1993) these words are common knowledge to people and researchers like me. 





No comments:

Post a Comment

Is Juniper Publishers Legit in 2025? A Transparent Review for Researchers

  Is Juniper Publishers Legit in 2025? A Transparent Review for Researchers   In 2025, the academic publishing landscape continues to evol...